Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-center Consecutive Series Study of Subjects Treated With the REDAPT™ Revision Femoral System

NCT02344160 is registered in ClinicalTrials.gov with Smith & Nephew, Inc. as lead sponsor.

NCT NCT02344160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02344160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-center Consecutive Series Study of Subjects Treated With the REDAPT™ Revision Femoral System
Lead sponsor
Smith & Nephew, Inc.
Phase
Observational
Overall status
Withdrawn
Start date
December 31, 2014
Completion date
December 31, 2028
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

total hip arthroplasty (tha)